39 reports

  • TREATMENT GUIDELINES FOR ANGINA PECTORIS
  • CLASSIFICATION FOR ANGINA PECTORIS

Angina caused by walking one or two blocks on the level and climbing one flight of stairs under at a normal pace.

  • Angina
  • Therapy
  • United States
  • Forecast
  • American Heart Association, Inc.
  • Angina Pectoris: Executive Summary
  • IN BUILDING THIS FORECAST, GLOBALDATA EPIDEMIOLOGISTS DEFINED THE DIAGNOSED INCIDENT AND DIAGNOSED PREVALENT CASES OF ANGINA PECTORIS AS THE SUM OF THE STABLE ANGINA, UNSTABLE ANGINA, PRINZMETAL ANGINA, AND MICROVASCULAR ANGINA CASES.

DOI: ##. ##/ ECR. 2018:##:##.

  • Angina
  • Chronic Disease
  • Pathology
  • United States
  • Forecast
  • Introduction
  • ANGINA PECTORIS MARKET IN APAC

Ramipril is one of the major angiotensin-converting enzyme inhibitors used by patients with angina pectoris.

  • Angina
  • Beta-Blocker
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG

2019 Future of Angina/ Angina Pectoris R& D Pipeline Drugs and Companies- Analysis of Global Angina (Angina Pectoris) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments ##.

  • Angina
  • Chronic Disease
  • Pathology

Refractory Angina (RA)- Epidemiology Forecast to 2030 ##.

  • Angina
  • France
  • Italy
  • United Kingdom
  • United States
  • Prevalence of angina pectoris, males (000s)
  • TOP-LINE PREVALENCE FOR ANGINA PECTORIS

PLoS One. 2012; ##(##):e## ##.

  • Angina
  • Chronic Disease
  • Pathology

Angina Pectoris Drugs Market Analysis, By Therapeutic Class, By Major Markets And Segment Forecasts, 2016 - 2022 Chapter ## Research Methodology ##. ##.

  • Angina
  • United States
  • Forecast
  • DISEASE DEFINITION
  • NITRATES

Chest pain (angina) TYPES OF ANGINA Angina Stable angina/ Angina pectoris Unstable angina Types of angina Stable angina/ Angina pectoris This is the most common type of angina.

  • Angina
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Angina (Angina Pectoris) - Overview
  • Angina (Angina Pectoris) - Dormant Projects

Each Unit will consist of one (##) post-Consolidation common share of the Company and one (##) share purchase warrant.

  • Angina
  • Therapy
  • United States
  • Product Initiative
  • Hemostemix, Ltd.
  • Angina (Angina Pectoris) - Overview
  • Angina (Angina Pectoris) - Dormant Projects

These subgroups include patients who have been diagnosed with (##) progressive coronary artery disease and who have reached clinically defined stages in their disease cycle; (##) " female pattern" angina; (##) Cardiac Syndrome X; and (##) certain orphan medical indications inc

  • Angina
  • Hospital
  • United States
  • Product Initiative
  • Hemostemix, Ltd.

Angina (Angina Pectoris) Global Clinical Trials Review, H##, 2020 List of Tables List of Figures Report Guidance GlobalData Clinical Trials Report Coverage Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Five Countries Contributing to Clinical Trials

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Therapy
  • World
  • CHRONIC STABLE ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, KEY SPONSORS, 2019*
  • CHRONIC STABLE ANGINA THERAPEUTICS CLINICAL TRIALS, CENTRAL AND SOUTH AMERICA, TOP COUNTRIES, 2019*

CLINICAL TRIALS BY PHASE IN E## COUNTRIES CHRONIC STABLE ANGINA THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2019* CHRONIC STABLE ANGINA THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2019* CHRONIC STABLE ANGINA THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY

  • Angina
  • Cardiovascular Disease
  • Clinical Trial
  • Therapy
  • World
  • Chronic Stable Angina clinical trials conducted
  • CHRONIC STABLE ANGINA THERAPEUTICS CLINICAL TRIALS, CENTRAL AND SOUTH AMERICA, TOP COUNTRIES, 2019*

CLINICAL TRIALS BY PHASE IN E## COUNTRIES CHRONIC STABLE ANGINA THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2019* CHRONIC STABLE ANGINA THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2019* CHRONIC STABLE ANGINA THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY

  • Angina
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative

Angina - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 ##.

  • Angina
  • Chronic Disease
  • United States
  • World
  • TOP COMPANIES PARTICIPATING IN VASOSPASTIC ANGINA THERAPEUTICS CLINICAL TRIALS
  • VASOSPASTIC ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2018*

VASOSPASTIC ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS VASOSPASTIC ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* VASOSPASTIC ANGINA THERAPEUTICS CLINICAL TR

  • Angina
  • Cardiovascular Drug
  • Clinical Trial
  • World
  • Product Initiative
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF UNSTABLE ANGINA TO CARDIOVASCULAR CLINICAL TRIALS
  • PROPORTION OF UNSTABLE ANGINA TO CARDIOVASCULAR CLINICAL TRIALS, E7 COUNTRIES (%), 2018*

CLINICAL TRIALS BY PHASE IN G## COUNTRIES UNSTABLE ANGINA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* UNSTABLE ANGINA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* Country Name Phase IV Phase III/ IV Phase III Phase II/ III Phase II Phase I Phas

  • Angina
  • Blood Disease
  • Cardiovascular Disease
  • Clinical Trial
  • World
  • TOP COMPANIES PARTICIPATING IN STABLE ANGINA THERAPEUTICS CLINICAL TRIALS
  • STABLE ANGINA THERAPEUTICS MARKET, GLOBAL, CLINICAL TRIALS BY SPONSOR TYPE (%), 2018*

The prominent features of this report are - ##.

  • Angina
  • Cardiovascular Disease
  • Clinical Trial
  • Therapy
  • World
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF REFRACTORY ANGINA TO CARDIOVASCULAR CLINICAL TRIALS
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF REFRACTORY ANGINA TO CARDIOVASCULAR CLINICAL TRIALS

REFRACTORY ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* REFRACTORY ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* REFRACTORY ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* Company Name Le

  • Angina
  • Clinical Trial
  • World
  • Product Initiative
  • Les Laboratoires Servier SAS

Angina (Angina Pectoris) Drug Pipeline, H##- 2019 ## Phase ## Pipeline Drug Details ##. ## Angina (Angina Pectoris)- Phase ## Drug Details ##. ## Angina (Angina Pectoris)- Phase ## Drug Overview ##. ## Angina (

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Pathology

Angina (Angina Pectoris) - Pipeline Insight, 2019 ##.

  • Angina
  • Chronic Disease
  • Pathology

Angina (Angina Pectoris) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R& D pipeline updates, status and outlook ##.

  • Angina
  • Chronic Disease
  • Pathology
  • Pharmaceutical

Insights into Angina (Angina Pectoris) Pipeline ##.

  • Angina
  • Chronic Disease
  • Pathology
  • World

The report focuses on drugs and therapies being evaluated for Angina (Angina Pectoris) treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Pathology

The report focuses on drugs and therapies being evaluated for Refractory Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology

The report focuses on drugs and therapies being evaluated for Vasospastic Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology

The report focuses on drugs and therapies being evaluated for Unstable Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development

The report focuses on drugs and therapies being evaluated for Stable Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development

The report focuses on drugs and therapies being evaluated for Chronic Stable Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development

2019 Vasospastic Angina Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology

2019 Unstable Angina Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development